North America Ophthalmic Photocoagulator Market Size & Outlook
North America ophthalmic photocoagulator market, 2016-2028 (US$M)
Related Markets
North America ophthalmic photocoagulator market highlights
- The North America ophthalmic photocoagulator market generated a revenue of USD 52.2 million in 2021.
- The market is expected to grow at a CAGR of 4.1% from 2022 to 2028.
- In terms of segment, diabetic retinopathy was the largest revenue generating application in 2021.
- Diabetic Retinopathy is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2022 to 2028.
North America data book summary
| Market revenue in 2021 | USD 52.2 million |
| Market revenue in 2028 | USD 69.3 million |
| Growth rate | 4.1% (CAGR from 2021 to 2028) |
| Largest segment | Diabetic retinopathy |
| Fastest growing segment | Diabetic Retinopathy |
| Historical data covered | 2016 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glaucoma, Diabetic Retinopathy, Age Related Macular Degeneration, Macular Edema |
| Key market players worldwide | Lumenis, IRIDEX Corp, Alcon Inc, Quantel Medical, Nidek Medical, Johnson & Johnson, Topcon Corp, Bausch & Lomb Corp, Meridian Bioscience |
Other key industry trends
- In terms of revenue, North America region accounted for 33.8% of the global ophthalmic photocoagulator market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 46.6 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Photocoagulator Market Scope
Ophthalmic Photocoagulator Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America ophthalmic photocoagulator market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic photocoagulator market will help companies and investors design strategic landscapes.
Diabetic retinopathy was the largest segment with a revenue share of 28.74% in 2021. Horizon Databook has segmented the North America ophthalmic photocoagulator market based on glaucoma, diabetic retinopathy, age related macular degeneration, macular edema covering the revenue growth of each sub-segment from 2016 to 2028.
Reasons to subscribe to North America ophthalmic photocoagulator market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America ophthalmic photocoagulator market databook
-
Our clientele includes a mix of ophthalmic photocoagulator market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America ophthalmic photocoagulator market , including forecasts for subscribers. This continent databook contains high-level insights into North America ophthalmic photocoagulator market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
North America ophthalmic photocoagulator market size, by country, 2016-2028 (US$M)
North America Ophthalmic Photocoagulator Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
